InsidersTradesSigma
콜마비앤에이치 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 콜마비앤에이치 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 콜마비앤에이치 has logged 54 public disclosures. Market capitalisation: €235.7bn. The latest transaction was disclosed on 29 June 2026 (Other). Among the most active insiders: 콜마홀딩스. All data is openly available.
54
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,452 of 26,293 companies
32.3
score / 100
Value44
Quality21
FCF yld6.4%
Earn yld-9.4%
EV/EBITDA·
ROE-0.5%
Gross mgn14%
Net mgn-3.9%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
Declarations54 total
25 of 54 declarations
About 콜마비앤에이치
콜마비앤에이치 operates in the health and pharmaceutical sector, listed on the XKRX market. The company specializes in the manufacturing of pharmaceutical and healthcare products.